Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1500 | Rucaparib | 0.001 | 0.64032 | |
| HCC1500 | RO-3306 | 3.16227766017 | 0.64032 | |
| HCC1500 | Senexin B | 0.001 | 0.64032 | |
| HCC1500 | Alvocidib | 0.00316227766017 | 0.64032 | |
| HCC1806 | THZ1 | 0.316227766 | 0.98083 | |
| HCC1500 | Alvocidib | 0.000316227766017 | 0.64032 | |
| HCC1500 | GSK2334470 | 0.00316227766017 | 0.64032 | |
| HCC1806 | BMS-265246 | 3.16227766 | 0.98083 | |
| HCC1500 | AZD6738 | 0.1 | 0.64032 | |
| HCC1500 | Ulixertinib | 3.16227766 | 0.64032 | |
| HCC1500 | Ulixertinib | 0.1 | 0.64032 | |
| HCC1500 | MK 1775 | 0.001 | 0.64032 | |
| MCF7 | MK 1775 | 1.0 | 0.98664 | |
| HCC1500 | AZD5363 | 3.16227766017 | 0.64032 | |
| HCC1500 | THZ1 | 0.000316227766017 | 0.64032 | |
| MCF7 | MK 1775 | 3.16227766 | 0.98664 | |
| MCF7 | MK 1775 | 10.0 | 0.98664 | |
| HCC1395 | AZD6738 | 1.0 | 0.90003 | |
| HCC1395 | AZD6738 | 3.16227766017 | 0.90003 | |
| CAL-120 | Alvocidib | 0.316227766017 | 0.98534 | |
| SK-BR-3 | AZD6738 | 10.0 | 0.96172 | |
| HCC1500 | MK 1775 | 3.16227766017 | 0.64032 | |
| HCC1500 | Ulixertinib | 0.003162278 | 0.64032 | |
| HCC1500 | THZ1 | 0.001 | 0.64032 | |
| HCC1500 | Alvocidib | 0.316227766017 | 0.64032 |